UY39744A - Composición farmacéutica que comprende un agonista de gpr40 y un inhibidor de sglt-2 - Google Patents
Composición farmacéutica que comprende un agonista de gpr40 y un inhibidor de sglt-2Info
- Publication number
- UY39744A UY39744A UY0001039744A UY39744A UY39744A UY 39744 A UY39744 A UY 39744A UY 0001039744 A UY0001039744 A UY 0001039744A UY 39744 A UY39744 A UY 39744A UY 39744 A UY39744 A UY 39744A
- Authority
- UY
- Uruguay
- Prior art keywords
- sglt
- inhibitor
- pharmaceutical composition
- composition including
- gpr40 agonist
- Prior art date
Links
- DGENZVKCTGIDRZ-UHFFFAOYSA-N 3-[4-[(3-phenoxyphenyl)methylamino]phenyl]propanoic acid Chemical compound C1=CC(CCC(=O)O)=CC=C1NCC1=CC=CC(OC=2C=CC=CC=2)=C1 DGENZVKCTGIDRZ-UHFFFAOYSA-N 0.000 title abstract 2
- 229940125827 GPR40 agonist Drugs 0.000 title abstract 2
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
<p>Se divulga aquí una composición farmacéutica que incluye un agonista de GPR40 y un inhibidor de SGLT-2, un método de preparación de la misma, y un método de tratamiento de la diabetes mellitus de tipo 2 y similares utilizando la misma. [Dibujo representativo] FIG. 1</p>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20210055992 | 2021-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY39744A true UY39744A (es) | 2022-11-30 |
Family
ID=83848392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001039744A UY39744A (es) | 2021-04-29 | 2022-04-28 | Composición farmacéutica que comprende un agonista de gpr40 y un inhibidor de sglt-2 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP4329756A1 (es) |
JP (1) | JP2024515137A (es) |
KR (1) | KR20240004285A (es) |
CN (1) | CN117241798A (es) |
AR (1) | AR125494A1 (es) |
AU (1) | AU2022266499A1 (es) |
BR (1) | BR112023022114A2 (es) |
CA (1) | CA3217858A1 (es) |
IL (1) | IL307623A (es) |
TW (1) | TW202308620A (es) |
UY (1) | UY39744A (es) |
WO (1) | WO2022231357A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7582803B2 (en) * | 2005-09-14 | 2009-09-01 | Amgen Inc. | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders |
WO2017180457A1 (en) * | 2016-04-11 | 2017-10-19 | Janssen Pharmaceutica Nv | Gpr40 agonists in anti-diabetic drug combinations |
BR112018073688A2 (pt) * | 2016-05-20 | 2019-02-26 | Center Laboratories, Inc. | método de tratamento de hiperglicemia |
CN109640993B (zh) * | 2016-08-12 | 2021-07-09 | 诺麦塔制药有限公司 | 包含阿莫地喹及抗糖尿病药物作为有效成分的用于预防或治疗糖尿病的药学组合物 |
KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
-
2022
- 2022-04-28 JP JP2023565557A patent/JP2024515137A/ja active Pending
- 2022-04-28 IL IL307623A patent/IL307623A/en unknown
- 2022-04-28 EP EP22796189.3A patent/EP4329756A1/en active Pending
- 2022-04-28 KR KR1020237034149A patent/KR20240004285A/ko unknown
- 2022-04-28 WO PCT/KR2022/006120 patent/WO2022231357A1/en active Application Filing
- 2022-04-28 BR BR112023022114A patent/BR112023022114A2/pt unknown
- 2022-04-28 CN CN202280031057.0A patent/CN117241798A/zh active Pending
- 2022-04-28 CA CA3217858A patent/CA3217858A1/en active Pending
- 2022-04-28 TW TW111116273A patent/TW202308620A/zh unknown
- 2022-04-28 UY UY0001039744A patent/UY39744A/es unknown
- 2022-04-28 AU AU2022266499A patent/AU2022266499A1/en active Pending
- 2022-04-29 AR ARP220101132A patent/AR125494A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112023022114A2 (pt) | 2024-01-30 |
AU2022266499A1 (en) | 2023-11-09 |
KR20240004285A (ko) | 2024-01-11 |
IL307623A (en) | 2023-12-01 |
WO2022231357A1 (en) | 2022-11-03 |
CA3217858A1 (en) | 2022-11-03 |
JP2024515137A (ja) | 2024-04-04 |
TW202308620A (zh) | 2023-03-01 |
CN117241798A (zh) | 2023-12-15 |
EP4329756A1 (en) | 2024-03-06 |
AR125494A1 (es) | 2023-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062130A2 (es) | Metodo para mejorar el crecimiento de las plantas | |
BR9608547A (pt) | Método para melhorar a sa·de animal | |
ECSP066662A (es) | Preparación farmacéutica que comprende un anticuerpo contra el receptor egf | |
PE20061327A1 (es) | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
BRPI0417684A (pt) | composto, composição farmacêutica, e, uso de um composto | |
ES2039939T3 (es) | Un obturador para protesis de valvula cardiaca, una protesis de valvula cardiaca, con dicho obturador, y un metodo para su fabricacion. | |
CL2003002048A1 (es) | Composicion granular soluble en agua que comprende al menos un 40% de un regulador de crecimiento de plantas, un adherente, un disacarido y un surfactante, donde el regulador de crecimiento de plantas es especialmente una giberelina, procedimiento de | |
RS50035B (sr) | Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje | |
ATE381291T1 (de) | Automatische ringförmige faltung zur mitralklappenreparatur | |
IS7535A (is) | Lyfjablanda | |
UY39744A (es) | Composición farmacéutica que comprende un agonista de gpr40 y un inhibidor de sglt-2 | |
AR025573A1 (es) | Composicion laxante | |
NO20052771L (no) | Kamille/Alovera-behandlet hanske. | |
DE50015623D1 (de) | Kovalent verbrückte insulindimere | |
CL2004000366A1 (es) | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. | |
DE69410634D1 (de) | Anatomisches und biologisches konservierungsmittel und verbesserte einbalsamierungszusammensetzung und -verfahren | |
UY28148A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
AR032455A1 (es) | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva | |
AR042111A1 (es) | Semillas recubiertas y metodo para recubrir semillas | |
AU2020344620A8 (en) | Implant comprising first and second sets of pillars for attaching a tendon or ligament to a hard tissue | |
DE602006008352D1 (de) | Hülsengesteuerter nachsteller | |
BR0108087A (pt) | Método e composições para o tratamento de uma doença inflamatória | |
FI130898B1 (fi) | Menetelmä bakteerin lepovaiheen muotojen tappamiseksi, elinkelpoisuuden vähentämiseksi ja/tai itämisen estämiseksi | |
ES2033181B1 (es) | Una tableta o capsula de herbicida para su aplicacion en arrozales. |